SCHEMBL20071341

SCHEMBL20071341

Cc1nc(CN2C3CC2CN(C)C3)cn1C

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.39
GNRHR P30968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20149628 0.85 RET (0.37) RET
SCHEMBL20148687 0.85 RET (0.40) RETGNRHR
SCHEMBL20070423 0.74 RET (0.38) RET
SCHEMBL20154486 0.74 RET (0.42) RET
SCHEMBL22031230 0.73 CYP2C9 (0.42) RETGNRHR
SCHEMBL22031280 0.73 RET (0.37) RET
SCHEMBL22031271 0.72 RET (0.37) RET
SCHEMBL22811895 0.72 RET (0.37) RET
SCHEMBL20070541 0.72 MAPT (0.42) RET
SCHEMBL20154485 0.71 RET (0.40) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753939-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma Inc. (US) 2020-12-23 EP disclosed
WO-2018071447-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed